Anticoagulation Management and Atrial Fibrillation http://www.acc.org/Feed?clinicalTopicID=07fcd7df-a463-421b-b927-d29a1be75766 Clinical Topic Feed: Anticoagulation Management and Atrial Fibrillation en Antiarrhythmic Drugs and Syncope or Pacemaker Implant in AF /Latest-in-Cardiology/Journal-Scans/2024/03/18/14/36/association-of-antiarrhythmic What is the association between antiarrhythmic drug (AAD) use and the risk of pacemaker implantation or syncope in patients with new-onset atrial fibrillation (AF) receiving early rhythm control therapy with AADs? 1710788340000 Articles and Stories Rivaroxaban Plus Amiodarone Increases Bleeding /Latest-in-Cardiology/Journal-Scans/2024/03/13/14/34/combination-of-rivaroxaban Is the incidence of bleeding higher in patients taking amiodarone plus rivaroxaban versus rivaroxaban alone when adjusted for baseline differences? 1710349380000 Articles and Stories Ischemic Stroke Severity After LAAC vs. NOAC /Latest-in-Cardiology/Journal-Scans/2024/02/26/19/42/severity-of-ischemic-stroke Is there a difference in the severity of ischemic stroke in patients with atrial fibrillation (AF) who have undergone left atrial appendage closure (LAAC) versus patients on direct oral anticoagulation (NOAC)? 1708980240000 Articles and Stories Eagle’s Eye View: NOAC vs. Warfarin For AFib, Sex Disparities in Medical-Guided Therapy Among HFrEF Patients, Polygenic Risk in Families With Spontaneous SCAD /Latest-in-Cardiology/Articles/2024/01/30/15/33/eagles-eye-view-31jan2024 In this week’s View, Dr. Eagle discusses the use of non–Vitamin-K antagonist oral anticoagulants versus warfarin across the spectrum of body mass index and weight. 1706720400000 Articles and Stories NOAC vs. Warfarin for AF Across BMI and Body Weight /Latest-in-Cardiology/Journal-Scans/2024/01/26/14/48/efficacy-and-safety-of-noac What is the efficacy and safety of non–vitamin-K antagonist oral anticoagulants (NOACs) across the spectrum of body mass index (BMI) and body weight (BW)? 1706289180000 Articles and Stories New in Clinical Documents | ACC/AHA Guideline Focuses on Diagnosis, Management of AFib /Latest-in-Cardiology/Articles/2024/01/01/01/42/new-in-clinical-documents-acc-aha-guideline-focuses-on-diagnosis-management-of-afib The newest clinical guideline released by the ACC and the American Heart Association (AHA) provides new and updated recommendations for preventing and optimally managing atrial fibrillation (AFib). 1704492240000 Articles and Stories Eagle's Eye View: Key Points in the 2023 AFib Guideline /Latest-in-Cardiology/Articles/2023/12/01/15/46/eagles-eye-view-06dec2023 In this week’s View, Dr. Eagle explores stroke and bleeding risk in patients with atrial fibrillation and a CHA2DS2-VASC risk score of 1. 1701882000000 Articles and Stories Journal Wrap /Latest-in-Cardiology/Articles/2023/12/01/01/42/journal-wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC.org Editorial Board led by Kim A. Eagle, MD, MACC. 1701464460000 Articles and Stories Stroke and Bleeding Risk in AF With CHA2DS2-VASc Score of One /Latest-in-Cardiology/Journal-Scans/2023/11/29/16/39/stroke-and-bleeding-risk What is the next clinical benefit of oral anticoagulation (OAC) therapy for patients with atrial fibrillation (AF) and an intermediate risk of stroke? 1701282660000 Articles and Stories Eagle’s Eye View: What Are the Cardiovascular Effects of Novel Weight Loss Therapies? /Latest-in-Cardiology/Articles/2023/11/22/15/19/eagles-eye-view-22nov2023 In this week’s View, Dr. Eagle explores a meta-analysis of direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation. 1700672400000 Articles and Stories